AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: HEMLIBRA (Genentech) (hemlibra.com)
A rare example of a site where regulatory scrutiny has successfully purged almost all marketing BS, leaving only minor metaphorical fluff in the headings. The data is precise, the citations are current, and the distance between claim and evidence is negligible.
Update the 2023 patient satisfaction survey data to reflect 2025-2026 metrics to avoid the aging evidence modifier. Implement Person schema for named ambassadors to strengthen the identity and authority pillar. Replace metaphorical headings like Sail into steady waters with more clinical H2s like Longitudinal Pharmacokinetic Stability to align with the high-density body text. Ensure all IQVIA data refreshes are explicitly dated to maintain the current credibility delta.
The site exhibits high substance, particularly in the body text which cites specific clinical metrics like a 4-week half-life and IQVIA claims data refreshed in September 2025. While headings such as Move on From Highs and Lows and Sail into steady waters are metaphorically fluffy, they are immediately followed by technical drug levels and therapeutic range data. There is significant specificity in the survey data provided, citing a blinded survey of exactly 62 people with a satisfaction breakdown (55/62 ranking 6 or 7).
AI crawlers don't scroll, click, or wait — they take whatever the raw HTML gives them. Start your free crawl layer inspection and see whether your site is actually reachable in an AI native environment.
There is virtually zero semantic drift across the 4-page sample. The homepage signal regarding consistent and sustained drug levels is meticulously supported by the technical explanation of the emicizumab half-life on the What is HEMLIBRA page. The transition from the marketing-oriented hero sections to the clinical reality of the subcutaneous injection process is consistent and transparent throughout the user journey.
Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.
Trust theatre is minimal as most claims are tied to verified datasets rather than unlinked testimonials. The 9 in 10 satisfaction claim is substantiated by a specific 2023 survey citation, and the #1 prescribed claim is linked to IQVIA insurance claims data. The site avoids generic star-rating widgets, using ambassador stories that are clearly labeled as personal experiences rather than universal outcomes.
The proof density is exceptionally high for the sector, with at least 8 distinct proof points including specific IQVIA data periods (Jul 24-Jun 25), exact patient survey counts (N=62), and defined therapeutic ranges. Every major efficacy claim includes a footnote marker leading to a source citation or a regulatory disclosure. The ratio of vague assertions to verifiable evidence is roughly 1:5, indicating a substance-heavy strategy.
To examine how structural entropy affects chunking and retrieval, review the Moz Semantic HTML audit. View the Moz Semantic HTML Audit for a complete example of heading logic, landmark integrity, and DOM depth diagnostics.
The site uses standard pharmaceutical template fingerprints including Patient Resources, For Healthcare Professionals, and Medication Guide sections. Cliché matches are present but controlled, including terms like mechanism of action and pharmacovigilance, which serve as functional jargon rather than fluff in this context. The value proposition is highly differentiated by the specific bridge mechanism described in the coagulation process.
Authority is primarily established through Genentech’s corporate identity rather than individual medical experts. While HEMLIBRA Ambassadors like Ian and Gabe are named, they lack associated Person schema, which slightly reduces digital footprint verification for the testimonials. However, the Organization schema for Genentech is robust and properly linked to its South San Francisco headquarters.
The disconnect is remarkably low because the site frames its performance claims within the context of clinical trial data and specific insurance claims registries. Bold assertions regarding proven bleed protection are directly adjacent to technical summaries of clinical trial outcomes. Marketing tone is present but remains subservient to the high-stakes safety and efficacy data required by regulatory bodies.
Medical Devices, Pharma & Biotech BS: HEMLIBRA (Genentech) (hemlibra.com)
The website is an exact match for the Pharma and Biotech category, specifically focusing on a prescription therapeutic for Hemophilia A. The content is heavily structured around regulatory requirements, including a Boxed Warning and extensive Important Safety Information (ISI).
AI cannot build a coherent graph if the same page resolves into multiple identities. Explore the URL & Canonical Hygiene Technical Framework to understand how identity stability prevents duplicate embeddings and semantic drift.
“The score is primarily driven by industry-standard clichés in the Commodity Fingerprint pillar and minor heading fluff in Information Density. Semantic coherence and proof pathways are near-perfect, resulting in one of the lowest BS scores possible for a commercial pharmaceutical entity.”